North American countries combined contribute around 24% of the global market for anticoccidial drugs. The demand for anticoccidial drugs is expected to grow by CAGR of 3.4 percent in terms of revenues by 2021. A majority of this is being driven by the prophylactic usage of anticoccidials in animal feed. Another factor driving the sales of anticoccidials is the increasing intake of meat .Demand for meat based food products is expected to go up as the cost of production of feed crops increases. The US is the most major market for anti coccidials in North America accounting for a lions share of the market. Mexico follows a distant second and Canada third being driven mostly by the import from the US market.
The Market research report titled North America Anticoccidial Drugs Market In Animal Health - Trends And Forecasts - (2016-21) by MORDOR INTELLIGENCEcategorizes the global anticoccidial market on the basis of Animal Types (Poultry, Cattle, Swine, and companion animals), by Drugs (Ionophore anticoccidials, Chemical derivative anticoccidials and Antibiotic anticoccidials) and by Geography (USA, Canada, Mexico, and Others).
Key players in the Anticoccidial Drugs Market areZoetis, Elanco (A division of Eli Lilly and Company), Merial, Bayer Health care Animal Healthcare division, Merck Animal Healthcare, Boehringer Ingelheim Animal Health, Virbac, and Novartis Animal Healthcare.
What the report offers:
Market Definition for the specified topic along with identification of key drivers and restraints for the market.